DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FAMCICLOVIR

« Back to Dashboard

All Clinical Trials for Famciclovir

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00098046	Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection	Completed	Novartis	Phase 3	2005-07-01	Varicella zoster virus causes chickenpox in children and shingles in adults. Chickenpox is usually a self-limiting illness characterized by fever and a rash. Serious complications can include secondary bacterial infections, pneumonia, and encephalitis. Anti-viral treatment is not a standard of care in immunocompetent children, but is recommended whenever a risk of complication exists. This study will evaluate the safety and blood levels of a new formulation of famciclovir in children 1-12 years of age.
NCT00098059	Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection	Completed	Novartis Pharmaceuticals	Phase 3	2005-02-01	This study will evaluate the safety and blood levels of a new pediatric formulation of Famvir in children 1-12 years of age. In Part A, patients will receive a single dose of famciclovir (12.5 mg/kg) to assess pharmacokinetics (PK) and safety. In Part B, patients will receive multiple doses of famciclovir alone or with concomitant oral anti-herpes therapy to assess safety and tolerability. Part B will start only after PK data from Part A had been analyzed.
NCT00129818	A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding	Completed	Novartis	Phase 4	2004-07-01	The study is designed to assess the efficacy and safety of famciclovir 250 mg twice a day (bid) suppressive treatment in men and women with herpes virus type 2 (HSV-2) infection, with and without a reported history of genital herpes and with or without herpes virus type 1 (HSV-1) seropositivity.

Clinical Trial Conditions for Famciclovir

Condition Name

Condition Name for Famciclovir
Intervention	Trials
Genital Herpes	4
Herpes Zoster	2
Herpes Simplex	2

Condition MeSH

Condition MeSH for Famciclovir
Intervention	Trials
Herpes Genitalis	6
Herpes Labialis	3
Herpes Zoster	2

Clinical Trial Locations for Famciclovir

Trials by Country

Trials by Country for Famciclovir
Location	Trials
United States	78
Canada	7
Brazil	5
Panama	3
Australia	2

Trials by US State

Trials by US State for Famciclovir
Location	Trials
Texas	6
Missouri	5
Ohio	4
North Carolina	4
Alabama	4

Clinical Trial Progress for Famciclovir

Clinical Trial Phase

Clinical Trial Phase for Famciclovir
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	7
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for Famciclovir
Clinical Trial Phase	Trials
Completed	16
Active, not recruiting	1
Recruiting	1

Clinical Trial Sponsors for Famciclovir

Sponsor Name

Sponsor Name for Famciclovir
Sponsor	Trials
Novartis	7
Novartis Pharmaceuticals	3
Roxane Laboratories	2

Sponsor Type

Sponsor Type for Famciclovir
Sponsor	Trials
Industry	20
Other	3